雅思

雅思雅思阅读阅读素材文章
北京上海天津重庆更多

2019年雅思考试阅读考前必看练习题5

2019年06月19日 14:54:20来源:雅思考试网
导读:阅读是我们考试科目中,比较好提分的一部分,所以想要让自己获得高分就要在阅读上多花些功夫,现在我们就来看一下这篇雅思考试阅读素材吧!

备考雅思考试的考生们,你们的阅读水平如何呢?阅读对我们来说还是比较容易提分的,小编这就为大家整理这篇阅读试题,在坦途网雅思考试频道还有很多相关的内容,希望考生们可以在考前多做一些题,熟悉考试形式和套路,这样才能取得好成绩。

1. The failure of a high-profile cholesterol drug has thrown a spotlight on the complicated machinery that regulates cholesterol levels. But many researchers remain confident that drugs to boost levels of ’good’ cholesterol are still one of the most promising means to combat spiralling heart disease.

2. Drug company Pfizer announced on 2 December that it was cancelling all clinical trials of torcetrapib, a drug designed to raise heart-protective high-density lipoproteins (HDLs)。 In a trial of 15000 patients, a safety board found that more people died or suffered cardiovascular problems after taking the drug plus a cholesterol-lowering statin than those in a control group who took the statin alone.

3. The news came as a kick in the teeth to many cardiologists because earlier tests in animals and people suggested it would lower rates of cardiovascular disease. “There have been no red flags to my knowledge,” says John Chapman, a specialist in lipoproteins and atherosclerosis at the National Institute for Health and Medical Research (INSERM) in Paris who has also studied torcetrapib. “This cancellation came as a complete shock.”

4. Torcetrapib is one of the most advanced of a new breed of drugs designed to raise levels of HDLs, which ferry cholesterol out of artery-clogging plaques to the liver for removal from the body. Specifically, torcetrapib blocks a protein called cholesterol ester transfer protein (CETP), which normally transfers the cholesterol from high-density lipoproteins to low density, plaque-promoting ones. Statins, in contrast, mainly work by lowering the ’bad’ low-density lipoproteins.

Under pressure

5. Researchers are now trying to work out why and how the drug backfired, something that will not become clear until the clinical details are released by Pfizer. One hint lies in evidence from earlier trials that it slightly raises blood pressure in some patients. It was thought that this mild problem would be offset by the heart benefits of the drug. But it is possible that it actually proved fatal in some patients who already suffered high blood pressure. If blood pressure is the explanation, it would actually be good news for drug developers because it suggests that the problems are specific to this compound. Other prototype drugs that are being developed to block CETP work in a slightly different way and might not suffer the same downfall.

6. But it is also possible that the whole idea of blocking CETP is flawed, says Moti Kashyap, who directs atherosclerosis research at the VA Medical Center in Long Beach, California. When HDLs excrete cholesterol in the liver, they actually rely on LDLs for part of this process. So inhibiting CETP, which prevents the transfer of cholesterol from HDL to LDL, might actually cause an abnormal and irreversible accumulation of cholesterol in the body. “You’re blocking a physiologic mechanism to eliminate cholesterol and effectively constipating the pathway,” says Kashyap.

Going up

7. Most researchers remain confident that elevating high density lipoproteins levels by one means or another is one of the best routes for helping heart disease patients. But HDLs are complex and not entirely understood. One approved drug, called niacin, is known to both raise HDL and reduce cardiovascular risk but also causes an unpleasant sensation of heat and tingling. Researchers are exploring whether they can bypass this side effect and whether niacin can lower disease risk more than statins alone. Scientists are also working on several other means to bump up high-density lipoproteins by, for example, introducing synthetic HDLs. “The only thing we know is dead in the water is torcetrapib, not the whole idea of raising HDL,” says Michael Miller, director of preventive cardiology at the University of Maryland Medical Center, Baltimore.

Questions 1-7

This passage has 7 paragraphs 1-7.

Choose the correct heading for each paragraph from the list of headings below.

Write the correct number i-ix in boxes 1-7 on your answer sheet.

List of Headings

i. How does torcetrapib work?

ii. Contradictory result prior to the current trial

iii. One failure may possibly bring about future success

iv. The failure doesn’t lead to total loss of confidence

v. It is the right route to follow

vi. Why it’s stopped

vii. They may combine and theoretically produce ideal result

viii. What’s wrong with the drug

ix. It might be wrong at the first place

Questions 7-13

Match torcetrapib,HDLs,statin and CETP with their functions (Questions 8-13)。。

Write the correct letter A, B, C or D in boxes 8-13 on your answer sheet.

NB You may use any letter more than once.

7.It has been administered to over 10,000 subjects in a clinical trial.

8.It could help rid human body of cholesterol.

9.Researchers are yet to find more about it.

10. It was used to reduce the level of cholesterol.

11. According to Kashyap, it might lead to unwanted result if it’s blocked.

12. It produced contradictory results in different trials.

13. It could inhibit LDLs.

List of choices

A. Torcetrapic

B. HDLS

C. Statin

D. CETP

(by Zhou Hong)

Suggested Answers and Explanations

1. vi

2. ii

3. vii 本段介绍了torcetrapib和statin的治病原理,但是同时短语“in contrast”与之前第二段后半段的内容呼应,暗示了这两种药在理论上能相辅相成,是理想的搭配。第1个选项无法涵盖整段意义,故选择i是错误的。

4. iii 本段分析了可能导致torcetrapibl临床试验失败的原因,后半段指出如果以上推测正确,那么未来的药物可借鉴这个试验,设法避免torcetrapib的缺陷,研制出有效的药物。viii选项无法涵盖后半段的意思。

5. ix 见首句。

6. v

7. A 见第二段。题目中administer一词意为“用药”,subject一词为“实验对象”之意。

8. B 见第四段“… to raise levels of HDLs, which ferry cholesterol out of artery- clogging plaques to the liver for removal from the body.”即HDLs的作用最终是将 choleserol清除出人体:“… for removal from the body”。

9. B 见第四段“But HDLs are complex and not entirely understood.”

10. C 见第二段“… plus a cholesterol-lowering statin”,即statin是可以降低cholesterol的。

11. D 见第六段 “So inhibiting CETP, … might actually cause an abnormal and irreversible accumulation of cholesterol in the body.

12. A 见第三段。

13. C 见第四段“Statins, in contrast, mainly work by lowering the ’bad’ low-density lipoproteins

上面的内容大家都看完了吧,如果有不会的题目,一定要及时解决,多问问,这样才能体现试题的作用!如果还想了解更多雅思内容请到坦途网来搜索,不只是模拟题,考点和雅思考试成绩查询等新鲜资讯小编都有分享哦!

温馨提示:因考试政策、内容不断变化与调整,坦途网提供的以上信息仅供参考,如有异议,请考生以权威部门公布的内容为准!

雅思培训课程免费试听

预约免费体验课

教育顾问会第一时间安排您的体验课!

课程预约立即提交
最新文章
电话咨询在线咨询资料领取